Loading…
Loading…
Apellis Pharmaceuticals APLS has outperformed the market over the past 5 years by 10.69% on an annualized basis producing an average annual return of 23.52%. Currently, Apellis Pharmaceuticals has a market capitalization of $7.02 billion.
Buying $1000 In APLS: If an investor had bought $1000 of APLS stock 5 years ago, it would be worth $3,017.45 today based on a price of $58.20 for APLS at the time of writing.
Apellis Pharmaceuticals’s Performance Over Last 5 Years
Finally — what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.